The Mayo Clinic experience with the use of kinase inhibitors, ipilimumab, bevacizumab, and local therapies in the treatment of metastatic uveal melanoma

Justin C. Moser, Jose S. Pulido, Roxana S. Dronca, Robert R. McWilliams, Svetomir N. Markovic, Aaron S. Mansfield

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'The Mayo Clinic experience with the use of kinase inhibitors, ipilimumab, bevacizumab, and local therapies in the treatment of metastatic uveal melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences